A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil

Masayuki Miyazaki, Nobito Higuchi, Masatake Tanaka, Akihiro Ueda, Masaki Kato, Yuji Tsuji, Kazuhiro Kotoh, Ryoichi Takyanagi

研究成果: ジャーナルへの寄稿記事

抄録

A 49-year-old man was admitted to our hospital suffering from acute hepatitis exacerbation caused by hepatitis B virus in July 2008. He had been diagnosed as chronic hepatitis B in 1999 and been successfully treated with lamivudine. In 2004, he experienced the first breakthrough hepatitis, which was controlled with an addition of adefovir dipivoxil to lamivudine. On admission, we found the elevation of the serum HBV-DNA level, which was revealed to contain the adefovir dipivoxil-resistant mutations: A181V/T and N236T. Although the appearance of mutations against adefovir dipivoxil has been described in some reports, it was rare that such mutations caused breakthrough hepatitis. We applied him the combination therapy with adefovir dipivoxil and entecavir, which decreased the serum HBV-DNA and alanine aminotransferase concentration within a month.

元の言語英語
ページ(範囲)514-519
ページ数6
ジャーナルActa Hepatologica Japonica
50
発行部数9
DOI
出版物ステータス出版済み - 10 14 2009

Fingerprint

Lamivudine
Hepatitis
Mutation
DNA
Chronic Hepatitis B
Therapeutics
Serum
Alanine Transaminase
Hepatitis B virus
adefovir dipivoxil

All Science Journal Classification (ASJC) codes

  • Hepatology

これを引用

A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil. / Miyazaki, Masayuki; Higuchi, Nobito; Tanaka, Masatake; Ueda, Akihiro; Kato, Masaki; Tsuji, Yuji; Kotoh, Kazuhiro; Takyanagi, Ryoichi.

:: Acta Hepatologica Japonica, 巻 50, 番号 9, 14.10.2009, p. 514-519.

研究成果: ジャーナルへの寄稿記事

Miyazaki, Masayuki ; Higuchi, Nobito ; Tanaka, Masatake ; Ueda, Akihiro ; Kato, Masaki ; Tsuji, Yuji ; Kotoh, Kazuhiro ; Takyanagi, Ryoichi. / A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil. :: Acta Hepatologica Japonica. 2009 ; 巻 50, 番号 9. pp. 514-519.
@article{ff18f7d0a5eb4580908a51c7f7286b05,
title = "A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil",
abstract = "A 49-year-old man was admitted to our hospital suffering from acute hepatitis exacerbation caused by hepatitis B virus in July 2008. He had been diagnosed as chronic hepatitis B in 1999 and been successfully treated with lamivudine. In 2004, he experienced the first breakthrough hepatitis, which was controlled with an addition of adefovir dipivoxil to lamivudine. On admission, we found the elevation of the serum HBV-DNA level, which was revealed to contain the adefovir dipivoxil-resistant mutations: A181V/T and N236T. Although the appearance of mutations against adefovir dipivoxil has been described in some reports, it was rare that such mutations caused breakthrough hepatitis. We applied him the combination therapy with adefovir dipivoxil and entecavir, which decreased the serum HBV-DNA and alanine aminotransferase concentration within a month.",
author = "Masayuki Miyazaki and Nobito Higuchi and Masatake Tanaka and Akihiro Ueda and Masaki Kato and Yuji Tsuji and Kazuhiro Kotoh and Ryoichi Takyanagi",
year = "2009",
month = "10",
day = "14",
doi = "10.2957/kanzo.50.514",
language = "English",
volume = "50",
pages = "514--519",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "9",

}

TY - JOUR

T1 - A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil

AU - Miyazaki, Masayuki

AU - Higuchi, Nobito

AU - Tanaka, Masatake

AU - Ueda, Akihiro

AU - Kato, Masaki

AU - Tsuji, Yuji

AU - Kotoh, Kazuhiro

AU - Takyanagi, Ryoichi

PY - 2009/10/14

Y1 - 2009/10/14

N2 - A 49-year-old man was admitted to our hospital suffering from acute hepatitis exacerbation caused by hepatitis B virus in July 2008. He had been diagnosed as chronic hepatitis B in 1999 and been successfully treated with lamivudine. In 2004, he experienced the first breakthrough hepatitis, which was controlled with an addition of adefovir dipivoxil to lamivudine. On admission, we found the elevation of the serum HBV-DNA level, which was revealed to contain the adefovir dipivoxil-resistant mutations: A181V/T and N236T. Although the appearance of mutations against adefovir dipivoxil has been described in some reports, it was rare that such mutations caused breakthrough hepatitis. We applied him the combination therapy with adefovir dipivoxil and entecavir, which decreased the serum HBV-DNA and alanine aminotransferase concentration within a month.

AB - A 49-year-old man was admitted to our hospital suffering from acute hepatitis exacerbation caused by hepatitis B virus in July 2008. He had been diagnosed as chronic hepatitis B in 1999 and been successfully treated with lamivudine. In 2004, he experienced the first breakthrough hepatitis, which was controlled with an addition of adefovir dipivoxil to lamivudine. On admission, we found the elevation of the serum HBV-DNA level, which was revealed to contain the adefovir dipivoxil-resistant mutations: A181V/T and N236T. Although the appearance of mutations against adefovir dipivoxil has been described in some reports, it was rare that such mutations caused breakthrough hepatitis. We applied him the combination therapy with adefovir dipivoxil and entecavir, which decreased the serum HBV-DNA and alanine aminotransferase concentration within a month.

UR - http://www.scopus.com/inward/record.url?scp=70349772124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349772124&partnerID=8YFLogxK

U2 - 10.2957/kanzo.50.514

DO - 10.2957/kanzo.50.514

M3 - Article

AN - SCOPUS:70349772124

VL - 50

SP - 514

EP - 519

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 9

ER -